Last updated on June 2019

Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)


Brief description of study

The main objectives of this study are:

  • Determine the difference in change from baseline in Six Minute Walk Distance (6MWD) when pulmonary rehabilitation (PR) is added to stable underlying nintedanib therapy in patients with idiopathic pulmonary fibrosis (IPF)
  • Determine the difference in change in Quality of Life (QoL) when pulmonary rehabilitation (PR) is added to stable underlying nintedanib therapy in patients with idiopathic pulmonary fibrosis (IPF)
  • Determine if there is an enduring effect in 6MWD, QoL and lung function from pulmonary rehabilitation (PR) when pulmonary rehabilitation (PR) is added to stable underlying nintedanib therapy in patients with idiopathic pulmonary fibrosis (IPF)

Clinical Study Identifier: NCT03717012

Find a site near you

Start Over

Minnesota Lung Center

Minneapolis, MN United States
  Connect »

Coastal Pulmonary & Crit Care

Saint Petersburg, FL United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Temple University Hospital

Philadelphia, PA United States
  Connect »

Metroplex Pul and Sleep Ctr

McKinney, TX United States
  Connect »

Moses H. Cone Memorial Hospital

Greensboro, NC United States
  Connect »

Suburban Lung Associates, SC

Elk Grove Village, IL United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.